-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the morning of December 3, the National Medical Security Administration held a press conference to announce the results of the 2021 National Medical Insurance Drug List adjustment and the official implementation time
.
It is worth noting that since then, many places have also begun to publish relevant documents to further promote the implementation of negotiated drugs and improve the supply guarantee level of negotiated drugs
.
For example, recently the Beijing Municipal Medical Insurance Bureau and the Municipal Human Resources and Social Insurance Bureau jointly issued the "Notice on Adjusting the Reimbursement Scope of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance in the City" (Jingyibaofa [2021] No.
34)
.
In accordance with the adjustment of the national drug catalogue of the 2021 edition, the notice made some adjustments to the city's medical insurance drug catalog, adjusted the scope and category of reimbursement for some drugs, and improved the reimbursement policy for outpatient special diseases and other medications in this city
.
Looking at the notice as a whole, it is worth mentioning that, after closely combining with the situation in Beijing, many reimbursement policies for drugs with higher annual costs have actually been adjusted and improved
.
For example, after a significant price cut for the treatment of spinal muscular atrophy, Noxinagen Sodium Injection, which has received much attention through national negotiations, the average annual drug cost of patients has dropped from one million yuan to about 100,000 yuan, and it is included in Beijing.
After the medical insurance reimbursement scope, children are hospitalized, the average annual personal burden of the drug is expected to be reduced to about 34,000 yuan
.
In addition, the "Pamipali Capsules" used to treat malignant tumors such as ovarian cancer and fallopian tube cancer have also seen a significant drop
.
It is understood that before the national implementation of drug negotiations, the average annual drug cost of patients was about 250,000 yuan.
After the country negotiated a substantial price reduction, the average annual drug cost of patients was about 120,000 yuan.
However, after the implementation of the outpatient special disease policy reimbursement in Beijing, retirement The average annual personal burden of the drug for employees will be further reduced to about 18,000 yuan
.
However, if there is an increase, there will be a decrease.
The 11 kinds of drugs deleted from the National Medical Insurance Drug List have also been deleted from the Beijing Medical Insurance Drug List.
The deleted drugs are mainly used in recent years and have a strong replaceability.
Medicines
.
It is worth noting that in addition to Beijing, the Hebei Provincial Medical Security Bureau and the Hebei Provincial Department of Human Resources and Social Security have recently formulated and issued the "Hebei Province Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2021 Edition)" (hereinafter referred to as "Drug List"), which will be officially implemented on January 1, 2022
.
It is understood that this adjustment, Hebei Province has adopted the national 2021 drug catalog as the standard
.
74 drugs were transferred to the catalog, and 11 drugs were removed from the catalog
.
Among them, 74 new drugs not listed in the catalog involve 21 clinical groups, 20 drugs for chronic diseases such as high blood pressure, diabetes, hyperlipidemia, and psychosis, 18 drugs for oncology, 15 drugs for hepatitis C and AIDS, and drugs for rare diseases.
There are 7 kinds of drugs for the treatment of new coronary pneumonia, 2 kinds of drugs for the treatment of new coronary pneumonia, and 12 kinds of drugs for other fields, and patients benefit from a wide range
.
The 11 drugs that have been brought out of the catalog are all drugs that have low clinical value and are replaceable, or have been purchased in a small amount on the national recruitment platform in recent years
.
The industry predicts that, as the time for the implementation of the new national medical insurance catalog is getting closer, more provinces and cities will accelerate the formulation and adjustment of their respective medical insurance drug catalogs based on actual conditions, so as to effectively improve the supply guarantee level of negotiated drugs.
Provide assistance to meet the needs of the insured patients for rational drug use
.
.
It is worth noting that since then, many places have also begun to publish relevant documents to further promote the implementation of negotiated drugs and improve the supply guarantee level of negotiated drugs
.
For example, recently the Beijing Municipal Medical Insurance Bureau and the Municipal Human Resources and Social Insurance Bureau jointly issued the "Notice on Adjusting the Reimbursement Scope of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance in the City" (Jingyibaofa [2021] No.
34)
.
In accordance with the adjustment of the national drug catalogue of the 2021 edition, the notice made some adjustments to the city's medical insurance drug catalog, adjusted the scope and category of reimbursement for some drugs, and improved the reimbursement policy for outpatient special diseases and other medications in this city
.
Looking at the notice as a whole, it is worth mentioning that, after closely combining with the situation in Beijing, many reimbursement policies for drugs with higher annual costs have actually been adjusted and improved
.
For example, after a significant price cut for the treatment of spinal muscular atrophy, Noxinagen Sodium Injection, which has received much attention through national negotiations, the average annual drug cost of patients has dropped from one million yuan to about 100,000 yuan, and it is included in Beijing.
After the medical insurance reimbursement scope, children are hospitalized, the average annual personal burden of the drug is expected to be reduced to about 34,000 yuan
.
In addition, the "Pamipali Capsules" used to treat malignant tumors such as ovarian cancer and fallopian tube cancer have also seen a significant drop
.
It is understood that before the national implementation of drug negotiations, the average annual drug cost of patients was about 250,000 yuan.
After the country negotiated a substantial price reduction, the average annual drug cost of patients was about 120,000 yuan.
However, after the implementation of the outpatient special disease policy reimbursement in Beijing, retirement The average annual personal burden of the drug for employees will be further reduced to about 18,000 yuan
.
However, if there is an increase, there will be a decrease.
The 11 kinds of drugs deleted from the National Medical Insurance Drug List have also been deleted from the Beijing Medical Insurance Drug List.
The deleted drugs are mainly used in recent years and have a strong replaceability.
Medicines
.
It is worth noting that in addition to Beijing, the Hebei Provincial Medical Security Bureau and the Hebei Provincial Department of Human Resources and Social Security have recently formulated and issued the "Hebei Province Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2021 Edition)" (hereinafter referred to as "Drug List"), which will be officially implemented on January 1, 2022
.
It is understood that this adjustment, Hebei Province has adopted the national 2021 drug catalog as the standard
.
74 drugs were transferred to the catalog, and 11 drugs were removed from the catalog
.
Among them, 74 new drugs not listed in the catalog involve 21 clinical groups, 20 drugs for chronic diseases such as high blood pressure, diabetes, hyperlipidemia, and psychosis, 18 drugs for oncology, 15 drugs for hepatitis C and AIDS, and drugs for rare diseases.
There are 7 kinds of drugs for the treatment of new coronary pneumonia, 2 kinds of drugs for the treatment of new coronary pneumonia, and 12 kinds of drugs for other fields, and patients benefit from a wide range
.
The 11 drugs that have been brought out of the catalog are all drugs that have low clinical value and are replaceable, or have been purchased in a small amount on the national recruitment platform in recent years
.
The industry predicts that, as the time for the implementation of the new national medical insurance catalog is getting closer, more provinces and cities will accelerate the formulation and adjustment of their respective medical insurance drug catalogs based on actual conditions, so as to effectively improve the supply guarantee level of negotiated drugs.
Provide assistance to meet the needs of the insured patients for rational drug use
.
